SAN DIEGO--(BUSINESS WIRE)--Kurin, Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that the United States Patent Office allowed its patent ...

SAN DIEGO--(BUSINESS WIRE)--Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that Oishei Children’s Hospital, a member of Kaleida ...

Steripath ® Initial Specimen Diversion Device ®, a clinically proven solution, enables hospitals to meet the new goal of 1% blood culture contamination as published in CLSI's M47 Principles and ...

The success of blood cultures is dependent on the collection of uncontaminated specimens, culture of a large volume of blood, and inoculation of multiple media types to maximize the recovery of most ...

SEATTLE, Dec. 7, 2021 /PRNewswire/ -- Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination for ...

SEATTLE, March 5, 2025 /PRNewswire/ — Magnolia Medical Technologies, Inc., the pioneer in Initial Specimen Diversion Device ® (ISDD ®) technology, today announced groundbreaking new findings from an ...

The FDA sent a letter to healthcare providers July 10 regarding the shortage, and the CDC released updated conservation strategies in a July 22 statement. The FDA estimates the shortage will continue ...

A blood culture is a routine laboratory test in which blood – or another sterile body fluid – is taken from a patient and inoculated into bottles containing specialized media to determine whether ...

FRANKLIN LAKES, N.J., Oct. 18, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Magnolia Medical Technologies, Inc., today ...